Protein transamidation by transglutaminase 2 in cells: a disputed Ca2+‐dependent action of a multifunctional protein

Transglutaminase 2 (TG2) is the first described cellular member of an enzyme family catalyzing Ca2+‐dependent transamidation of proteins. During the last two decades its additional enzymatic (GTP binding and hydrolysis, protein disulfide isomerase, protein kinase) and non‐enzymatic (multiple interactions in protein scaffolds) activities, which do not require Ca2+, have been recognized. It became a prevailing view that TG2 is silent as a transamidase, except in extreme stress conditions, in the intracellular environment characterized by low Ca2+ and high GTP concentrations. To counter this presumption a critical review of the experimental evidence supporting the role of this enzymatic activity in cellular processes is provided. It includes the structural basis of TG2 regulation through non‐canonical Ca2+ binding sites, mechanisms making it sensitive to low Ca2+ concentrations, techniques developed for the detection of protein transamidation in cells and examples of basic cellular phenomena as well as pathological conditions influenced by this irreversible post‐translational protein modification.

[1]  J. Vowinckel,et al.  Novel roles for biogenic monoamines: from monoamines in transglutaminase‐mediated post‐translational protein modification to monoaminylation deregulation diseases , 2011, The FEBS journal.

[2]  S. Kojima,et al.  New insights into the functions and localization of nuclear transglutaminase 2 , 2011, The FEBS journal.

[3]  A. Belkin Extracellular TG2: emerging functions and regulation , 2011, The FEBS journal.

[4]  M. Mattson,et al.  Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease. , 2011, Biochimica et biophysica acta.

[5]  R. Hsia,et al.  Unconventional Secretion of Tissue Transglutaminase Involves Phospholipid-Dependent Delivery into Recycling Endosomes , 2011, PloS one.

[6]  S. Hill,et al.  Inhibition of Tissue Transglutaminase 2 Attenuates Contractility of Pregnant Human Myometrium1 , 2011, Biology of reproduction.

[7]  N. Heisterkamp,et al.  Bcr is a substrate for Transglutaminase 2 cross-linking activity , 2011, BMC Biochemistry.

[8]  S. Kojima,et al.  In Situ Detection of Active Transglutaminases for Keratinocyte Type (TGase 1) and Tissue Type (TGase 2) Using Fluorescence-Labeled Highly Reactive Substrate Peptides , 2011, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[9]  N. Muma,et al.  Phospholipase C, Ca2+, and calmodulin signaling are required for 5-HT2A receptor-mediated transamidation of Rac1 by transglutaminase , 2011, Psychopharmacology.

[10]  C. Khosla,et al.  Dihydroisoxazole analogs for labeling and visualization of catalytically active transglutaminase 2. , 2011, Chemistry & biology.

[11]  I. Komáromi,et al.  Factor XIII: novel structural and functional aspects , 2011, Journal of thrombosis and haemostasis : JTH.

[12]  Changsun Choi,et al.  Transglutaminase 2 gene ablation protects against renal ischemic injury by blocking constant NF-κB activation. , 2010, Biochemical and biophysical research communications.

[13]  L. Fésüs,et al.  Tissue transglutaminase contributes to the all-trans-retinoic acid-induced differentiation syndrome phenotype in the NB4 model of acute promyelocytic leukemia. , 2010, Blood.

[14]  A. Ballabio,et al.  Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition , 2010, Nature Cell Biology.

[15]  C. Feighery,et al.  Coeliac disease autoantibodies mediate significant inhibition of tissue transglutaminase. , 2010, Clinical immunology.

[16]  Sama F. Sleiman,et al.  Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease , 2010, EMBO molecular medicine.

[17]  M. Akiyama,et al.  Identification of a preferred substrate peptide for transglutaminase 3 and detection of in situ activity in skin and hair follicles , 2010, The FEBS journal.

[18]  Soo-Youl Kim,et al.  I-kappaBalpha depletion by transglutaminase 2 and mu-calpain occurs in parallel with the ubiquitin-proteasome pathway. , 2010, Biochemical and biophysical research communications.

[19]  B. Han,et al.  Crystal structure of human transglutaminase 2 in complex with adenosine triphosphate. , 2010, International journal of biological macromolecules.

[20]  T. Sakai,et al.  Inhibition of tissue transglutaminase sensitizes TRAIL‐resistant lung cancer cells through upregulation of death receptor 5 , 2010, FEBS letters.

[21]  L. Sollid,et al.  Redox Regulation of Transglutaminase 2 Activity* , 2010, The Journal of Biological Chemistry.

[22]  T. Pozzan,et al.  Mitochondria: the calcium connection. , 2010, Biochimica et biophysica acta.

[23]  Rita Casadio,et al.  Thermodynamics of binding of regulatory ligands to tissue transglutaminase , 2010, Amino Acids.

[24]  A. Hmadcha,et al.  Pancreatic islet cells: A model for calcium‐dependent peptide release , 2010, HFSP journal.

[25]  K. Ha,et al.  Transglutaminase 2: a multi-functional protein in multiple subcellular compartments , 2010, Amino Acids.

[26]  J. Jeon,et al.  Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-κB activity in hypoxic tumor cells , 2010, Oncogene.

[27]  A. Nikitin,et al.  EGF potentiated oncogenesis requires a tissue transglutaminase-dependent signaling pathway leading to Src activation , 2010, Proceedings of the National Academy of Sciences.

[28]  M. Haber,et al.  Opposing Effects of Two Tissue Transglutaminase Protein Isoforms in Neuroblastoma Cell Differentiation* , 2009, The Journal of Biological Chemistry.

[29]  I. Korponay-Szabó,et al.  Functional significance of five noncanonical Ca2+‐binding sites of human transglutaminase 2 characterized by site‐directed mutagenesis , 2009, The FEBS journal.

[30]  G. Melino,et al.  Transglutaminase 2 is involved in autophagosome maturation , 2009, Autophagy.

[31]  N. Heisterkamp,et al.  Transglutaminase 2 Regulates the GTPase-activating Activity of Bcr* , 2009, The Journal of Biological Chemistry.

[32]  Michael Bader,et al.  Intracellular Serotonin Modulates Insulin Secretion from Pancreatic β-Cells by Protein Serotonylation , 2009, PLoS biology.

[33]  V. Villella,et al.  SUMOylation of Tissue Transglutaminase as Link between Oxidative Stress and Inflammation1 , 2009, Journal of Immunology.

[34]  B. Devreese,et al.  Transglutaminase-mediated Intramolecular Cross-linking of Membrane-bound α-Synuclein Promotes Amyloid Formation in Lewy Bodies* , 2009, The Journal of Biological Chemistry.

[35]  P. Matarrese,et al.  The adenine nucleotide translocator 1 acts as a type 2 transglutaminase substrate: implications for mitochondrial-dependent apoptosis , 2009, Cell Death and Differentiation.

[36]  Arthur J. L. Cooper,et al.  Transglutaminase activation in neurodegenerative diseases. , 2009, Future neurology.

[37]  G. Johnson,et al.  Intracellular Localization and Conformational State of Transglutaminase 2: Implications for Cell Death , 2009, PloS one.

[38]  Kenji Suzuki,et al.  Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1. , 2009, Gastroenterology.

[39]  A. Regan,et al.  Tissue Transglutaminase Is an Essential Participant in the Epidermal Growth Factor-stimulated Signaling Pathway Leading to Cancer Cell Migration and Invasion , 2009, The Journal of Biological Chemistry.

[40]  D. Matei,et al.  Tissue Transglutaminase Regulates Matrix Metalloproteinase-2 in Ovarian Cancer by Modulating cAMP-response Element-binding Protein Activity* , 2009, The Journal of Biological Chemistry.

[41]  György Vereb,et al.  Transglutaminase 2 Is Needed for the Formation of an Efficient Phagocyte Portal in Macrophages Engulfing Apoptotic Cells1 , 2009, The Journal of Immunology.

[42]  X. Chen,et al.  Neuroprotective Effects of Inositol 1,4,5-Trisphosphate Receptor C-Terminal Fragment in a Huntington's Disease Mouse Model , 2009, The Journal of Neuroscience.

[43]  Takeshi Sakaba,et al.  Multiple Roles of Calcium Ions in the Regulation of Neurotransmitter Release , 2008, Neuron.

[44]  Arthur Konnerth,et al.  Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer's Disease , 2008, Science.

[45]  Ilya Bezprozvanny,et al.  Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease , 2008, Trends in Neurosciences.

[46]  Brian J. Bacskai,et al.  Aβ Plaques Lead to Aberrant Regulation of Calcium Homeostasis In Vivo Resulting in Structural and Functional Disruption of Neuronal Networks , 2008, Neuron.

[47]  T. Patel,et al.  Transglutaminase-Catalyzed Transamidation: A Novel Mechanism for Rac1 Activation by 5-Hydroxytryptamine2A Receptor Stimulation , 2008, Journal of Pharmacology and Experimental Therapeutics.

[48]  D. Holtzman,et al.  Active and passive immunotherapy for neurodegenerative disorders. , 2008, Annual review of neuroscience.

[49]  V. Villella,et al.  Tissue Transglutaminase Activation Modulates Inflammation in Cystic Fibrosis via PPARγ Down-Regulation1 , 2008, The Journal of Immunology.

[50]  J. Repa,et al.  Elucidating a normal function of huntingtin by functional and microarray analysis of huntingtin-null mouse embryonic fibroblasts , 2008, BMC Neuroscience.

[51]  M. Omary,et al.  Extracellular Transglutaminase 2 Is Catalytically Inactive, but Is Transiently Activated upon Tissue Injury , 2008, PloS one.

[52]  M. Lemmon,et al.  Membrane recognition by phospholipid-binding domains , 2008, Nature Reviews Molecular Cell Biology.

[53]  C. Greenberg,et al.  The FASEB Journal • Research Communication Identification of two GTP-independent alternatively , 2022 .

[54]  A. Brunger,et al.  Transglutaminase 2 Undergoes a Large Conformational Change upon Activation , 2007, PLoS biology.

[55]  T. Hansen,et al.  Missense mutations in the TGM2 gene encoding transglutaminase 2 are found in patients with early‐onset type 2 diabetes , 2007, Human mutation.

[56]  D. Surmeier,et al.  Calcium, ageing, and neuronal vulnerability in Parkinson's disease , 2007, The Lancet Neurology.

[57]  H. Vogel,et al.  Structures and metal-ion-binding properties of the Ca2+-binding helix-loop-helix EF-hand motifs. , 2007, The Biochemical journal.

[58]  Olivier Thibault,et al.  Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store , 2007, Aging cell.

[59]  B. de Strooper,et al.  Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1. , 2007, The Journal of clinical investigation.

[60]  Ming Yan,et al.  Ethanol induced mitochondria injury and permeability transition pore opening: role of mitochondria in alcoholic liver disease. , 2007, World journal of gastroenterology.

[61]  R. Terkeltaub,et al.  Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement. , 2007, Gastroenterology.

[62]  L. Lorand,et al.  Mechanism of allosteric regulation of transglutaminase 2 by GTP , 2006, Proceedings of the National Academy of Sciences.

[63]  M. Endo,et al.  Two isoforms of tissue transglutaminase mediate opposing cellular fates , 2006, Proceedings of the National Academy of Sciences.

[64]  G. Johnson,et al.  Mutant Huntingtin Expression Induces Mitochondrial Calcium Handling Defects in Clonal Striatal Cells , 2006, Journal of Biological Chemistry.

[65]  Soo-Youl Kim,et al.  Transglutaminase 2 Mediates Polymer Formation of I-κBα through C-terminal Glutamine Cluster* , 2006, Journal of Biological Chemistry.

[66]  S. Datta,et al.  Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis. , 2006, Biochemistry.

[67]  M. Lanotte,et al.  Tissue-transglutaminase contributes to neutrophil granulocyte differentiation and functions. , 2006, Blood.

[68]  B. Strooper,et al.  Presenilins Form ER Ca2+ Leak Channels, a Function Disrupted by Familial Alzheimer's Disease-Linked Mutations , 2006, Cell.

[69]  R. Graham,et al.  Mutation of a Critical Arginine in the GTP-binding Site of Transglutaminase 2 Disinhibits Intracellular Cross-linking Activity* , 2006, Journal of Biological Chemistry.

[70]  J. Gready,et al.  The C‐type lectin‐like domain superfamily , 2005, The FEBS journal.

[71]  L. Lorand,et al.  Identification of a Novel Recognition Sequence for Fibronectin within the NH2-terminal β-Sandwich Domain of Tissue Transglutaminase* , 2005, Journal of Biological Chemistry.

[72]  L. Fésüs,et al.  Transglutaminase 2 in the balance of cell death and survival , 2005, FEBS letters.

[73]  Charles Auffray,et al.  Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[74]  R. Eckert,et al.  A novel transglutaminase activator forms a complex with type 1 transglutaminase , 2005, Oncogene.

[75]  P. Matarrese,et al.  Tissue Transglutaminase Is a Multifunctional BH3-only Protein* , 2004, Journal of Biological Chemistry.

[76]  T. Joh,et al.  Transglutaminase 2 induces NF-κB activation via a novel pathway in BV-2 microglia , 2004 .

[77]  Alex Y Strongin,et al.  Cell-surface-associated tissue transglutaminase is a target of MMP-2 proteolysis. , 2004, Biochemistry.

[78]  F. Rastinejad,et al.  The emerging structural understanding of transglutaminase 3. , 2004, Journal of structural biology.

[79]  B. Devreese,et al.  Cross‐linking of ubiquitin, HSP27, parkin and α‐synuclein by γ‐glutamyl‐ε‐lysine bonds in Alzheimer's neurofibrillary tangles , 2004 .

[80]  Suresh Mishra,et al.  Tissue Transglutaminase Has Intrinsic Kinase Activity , 2004, Journal of Biological Chemistry.

[81]  G. Johnson,et al.  Immunoblot analysis reveals that isopeptide antibodies do not specifically recognize the ε-(γ-glutamyl)lysine bonds formed by transglutaminase activity , 2004, Journal of Neuroscience Methods.

[82]  J. Jeon,et al.  Cell Type-specific Activation of Intracellular Transglutaminase 2 by Oxidative Stress or Ultraviolet Irradiation , 2004, Journal of Biological Chemistry.

[83]  M. Höltje,et al.  Serotonylation of Small GTPases Is a Signal Transduction Pathway that Triggers Platelet α-Granule Release , 2003, Cell.

[84]  L. Lorand,et al.  Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[85]  J. Jeon,et al.  Transglutaminase 2 inhibits Rb binding of human papillomavirus E7 by incorporating polyamine , 2003, The EMBO journal.

[86]  Masashi Kikuchi,et al.  A novel function of tissue-type transglutaminase: protein disulphide isomerase. , 2003, The Biochemical journal.

[87]  G. Johnson,et al.  Tissue Transglutaminase Directly Regulates Adenylyl Cyclase Resulting in Enhanced cAMP-response Element-binding Protein (CREB) Activation* , 2003, Journal of Biological Chemistry.

[88]  M. Hayden,et al.  Huntingtin and Huntingtin-Associated Protein 1 Influence Neuronal Calcium Signaling Mediated by Inositol-(1,4,5) Triphosphate Receptor Type 1 , 2003, Neuron.

[89]  D. Uhm,et al.  Glutamate-mediated [Ca2+]c dynamics in spontaneously firing dopamine neurons of the rat substantia nigra pars compacta , 2003, Journal of Cell Science.

[90]  Ulrich Baxa,et al.  Roles of Calcium Ions in the Activation and Activity of the Transglutaminase 3 Enzyme* , 2003, Journal of Biological Chemistry.

[91]  Zsuzsa Szondy,et al.  Transglutaminase 2-/- mice reveal a phagocytosis-associated crosstalk between macrophages and apoptotic cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[92]  S. Yi,et al.  Activation of in situ tissue transglutaminase by intracellular reactive oxygen species. , 2003, Biochemical and biophysical research communications.

[93]  P. Smethurst,et al.  Cross-linking of cellular proteins by tissue transglutaminase during necrotic cell death: a mechanism for maintaining tissue integrity. , 2003, The Biochemical journal.

[94]  Robert M. Graham,et al.  Transglutaminases: crosslinking enzymes with pleiotropic functions , 2003, Nature Reviews Molecular Cell Biology.

[95]  J. Jeon,et al.  Differential incorporation of biotinylated polyamines by transglutaminase 2 , 2003, FEBS letters.

[96]  Jing-kun Pan,et al.  Tissue Transglutaminase Mediates Activation of RhoA and MAP Kinase Pathways during Retinoic Acid-induced Neuronal Differentiation of SH-SY5Y Cells* , 2003, The Journal of Biological Chemistry.

[97]  Mauro Piacentini,et al.  Transglutaminase 2: an enigmatic enzyme with diverse functions. , 2002, Trends in biochemical sciences.

[98]  G. Melino,et al.  Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[99]  G. Melino,et al.  ‘Tissue’ transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease , 2002, Cell Death and Differentiation.

[100]  James R. Burke,et al.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines , 2002, Nature Neuroscience.

[101]  R. Cerione,et al.  Tissue Transglutaminase Protects against Apoptosis by Modifying the Tumor Suppressor Protein p110 Rb* , 2002, The Journal of Biological Chemistry.

[102]  K. Santacruz,et al.  Injury‐induced ‘switch’ from GTP‐regulated to novel GTP‐independent isoform of tissue transglutaminase in the rat spinal cord , 2002, Journal of neurochemistry.

[103]  L. Raymond,et al.  Increased Sensitivity to N-Methyl-D-Aspartate Receptor-Mediated Excitotoxicity in a Mouse Model of Huntington's Disease , 2002, Neuron.

[104]  S. N. Murthy,et al.  Conserved tryptophan in the core domain of transglutaminase is essential for catalytic activity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[105]  R. Graham,et al.  Targeted Inactivation of Gh/Tissue Transglutaminase II* , 2001, The Journal of Biological Chemistry.

[106]  K. Baker,et al.  Role of transglutaminase II in retinoic acid‐induced activation of RhoA‐associated kinase‐2 , 2001, The EMBO journal.

[107]  Z. Nemes,et al.  Nε(γ-glutamyl)lysine in cerebrospinal fluid marks Alzheimer type and vascular dementia 1 1 Abbreviations: AD: Alzheimer dementia, CSF: cerebrospinal fluid, IDP: Nε(γ-glutamyl)lysine isodipeptide, HPLC: high performance liquid chromatography, MMSE: mini-mental state examination , 2001, Neurobiology of Aging.

[108]  A. Hausladen,et al.  Calcium regulates S-nitrosylation, denitrosylation, and activity of tissue transglutaminase. , 2001, Biochemistry.

[109]  K. Santacruz,et al.  Intron-Exon Swapping of Transglutaminase mRNA and Neuronal Tau Aggregation in Alzheimer's Disease* , 2001, The Journal of Biological Chemistry.

[110]  G. Johnson,et al.  Tissue transglutaminase is essential for neurite outgrowth in human neuroblastoma SH-SY5Y cells , 2001, Neuroscience.

[111]  G. Melino,et al.  Gene Disruption of Tissue Transglutaminase , 2001, Molecular and Cellular Biology.

[112]  G. Johnson,et al.  Impaired Mitochondrial Function Results in Increased Tissue Transglutaminase Activity In Situ , 2000, Journal of neurochemistry.

[113]  G. Duncan,et al.  A human lens model of cortical cataract: Ca2+-induced protein loss, vimentin cleavage and opacification. , 2000, Investigative ophthalmology & visual science.

[114]  G. Mei,et al.  Opposite Effects of Ca2+ and GTP Binding on Tissue Transglutaminase Tertiary Structure* , 2000, The Journal of Biological Chemistry.

[115]  P. Steinert,et al.  Initiation of assembly of the cell envelope barrier structure of stratified squamous epithelia. , 1999, Molecular biology of the cell.

[116]  S. N. Murthy,et al.  Interactions of G(h)/transglutaminase with phospholipase Cdelta1 and with GTP. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[117]  G. Melino,et al.  Transglutaminase crosslinking and structural studies of the human small proline rich 3 protein , 1999, Cell Death and Differentiation.

[118]  M. Im,et al.  Calreticulin down-regulates both GTP binding and transglutaminase activities of transglutaminase II. , 1999, Biochemistry.

[119]  R. Casadio,et al.  The structural basis for the regulation of tissue transglutaminase by calcium ions. , 1999, European journal of biochemistry.

[120]  M. Levitt,et al.  Interaction of tissue transglutaminase with nuclear transport protein importin‐α3 , 1999, FEBS letters.

[121]  L. Lorand DRPLA aggregation and transglutaminase, revisited , 1998, Nature Genetics.

[122]  Yu-Wei Wu,et al.  Two distinct classes of rat intestinal mucosal enzymes incorporating putrescine into protein , 1998, FEBS letters.

[123]  T. Südhof,et al.  C2-domains, Structure and Function of a Universal Ca2+-binding Domain* , 1998, The Journal of Biological Chemistry.

[124]  L. Johnson,et al.  A novel calcium-independent enzyme capable of incorporating putrescine into proteins. , 1998, Biochemical and biophysical research communications.

[125]  S. Tsuji,et al.  Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch , 1998, Nature Genetics.

[126]  G. Johnson,et al.  Modulation of the in Situ Activity of Tissue Transglutaminase by Calcium and GTP* , 1998, The Journal of Biological Chemistry.

[127]  C. Greenberg,et al.  Regulation of Human Tissue Transglutaminase Function by Magnesium-Nucleotide Complexes , 1998, The Journal of Biological Chemistry.

[128]  R. Gonzales,et al.  Organization and structure of the human tissue transglutaminase gene. , 1997, Biochimica et biophysica acta.

[129]  R. Ádány,et al.  Identification of Cytoplasmic Actin as an Abundant Glutaminyl Substrate for Tissue Transglutaminase in HL-60 and U937 Cells Undergoing Apoptosis* , 1997, The Journal of Biological Chemistry.

[130]  A. Bielawska,et al.  Sphingosylphosphocholine Reduces the Calcium Ion Requirement for Activating Tissue Transglutaminase* , 1997, The Journal of Biological Chemistry.

[131]  O. Eizenberg,et al.  Expression of GTP-dependent and GTP-independent Tissue-type Transglutaminase in Cytokine-treated Rat Brain Astrocytes* , 1997, The Journal of Biological Chemistry.

[132]  R. Cerione,et al.  Biochemical Effects of Retinoic Acid on GTP-binding Protein/Transglutaminases in HeLa Cells , 1996, The Journal of Biological Chemistry.

[133]  R. Gonzales,et al.  A third human tissue transglutaminase homologue as a result of alternative gene transcripts. , 1996, Biochimica et biophysica acta.

[134]  P. Smethurst,et al.  Measurement of tissue transglutaminase activity in a permeabilized cell system: its regulation by Ca2+ and nucleotides. , 1996, The Biochemical journal.

[135]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[136]  B. Fraij GTP hydrolysis by human tissue transglutaminase homologue. , 1996, Biochemical and biophysical research communications.

[137]  P. Williamson,et al.  Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes , 1995, The Journal of experimental medicine.

[138]  D. Clapham,et al.  Calcium signaling , 1995, Cell.

[139]  R. Graham,et al.  Gh: a GTP-binding protein with transglutaminase activity and receptor signaling function. , 1994, Science.

[140]  J. Tschopp,et al.  Characterization of the endogenous deoxyribonuclease involved in nuclear DNA degradation during apoptosis (programmed cell death). , 1993, The EMBO journal.

[141]  R. Gonzales,et al.  A retinoic acid-inducible mRNA from human erythroleukemia cells encodes a novel tissue transglutaminase homologue. , 1992, The Journal of biological chemistry.

[142]  Y. Takeuchi,et al.  Putative nucleotide binding sites of guinea pig liver transglutaminase , 1992, FEBS letters.

[143]  K. N. Lee,et al.  Identification of transglutaminase substrates in HT29 colon cancer cells: use of 5-(biotinamido)pentylamine as a transglutaminase-specific probe. , 1992, Biochimica et biophysica acta.

[144]  A. Luini,et al.  Tetanus toxin potently stimulates tissue transglutaminase. A possible mechanism of neurotoxicity. , 1992, The Journal of biological chemistry.

[145]  K. Zatloukal,et al.  High amount of epsilon-(gamma-glutamyl)lysine cross-links in Mallory bodies. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[146]  R Llinás,et al.  Microdomains of high calcium concentration in a presynaptic terminal. , 1992, Science.

[147]  W. D. de Jong,et al.  The carboxy-terminal lysine of alpha B-crystallin is an amine-donor substrate for tissue transglutaminase. , 1992, European journal of biochemistry.

[148]  T. Szarvas,et al.  Presence and Possible Origin of ɛ(γ-Glutamyl)Lysine Isodipeptide in Human Plasma , 1992, Thrombosis and Haemostasis.

[149]  E. Chiocca,et al.  Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. , 1991, The Journal of biological chemistry.

[150]  E. Tarcsa,et al.  Formation of N epsilon-(gamma-glutamyl)-lysine isodipeptide in Chinese-hamster ovary cells. , 1989, The Biochemical journal.

[151]  M. Piacentini,et al.  Apoptotic hepatocytes become insoluble in detergents and chaotropic agents as a result of transglutaminase action , 1989, FEBS letters.

[152]  C. Bergamini GTP modulates calcium binding and cation‐induced conformational changes in erythrocyte transglutaminase , 1988, FEBS letters.

[153]  M. Piacentini,et al.  Free and protein-conjugated polyamines in mouse epidermal cells. Effect of high calcium and retinoic acid. , 1988, The Journal of biological chemistry.

[154]  P. Bungay,et al.  Transglutaminase-catalysed cross-linking of proteins phosphorylated in the intact glucose-stimulated pancreatic beta-cell. , 1988, Biochimica et biophysica acta.

[155]  A. Falus,et al.  Induction and activation of tissue transglutaminase during programmed cell death , 1987, FEBS letters.

[156]  C. Bergamini,et al.  Inhibition of erythrocyte transglutaminase by GTP. , 1987, Biochimica et biophysica acta.

[157]  K. Achyuthan,et al.  Identification of a guanosine triphosphate-binding site on guinea pig liver transglutaminase. Role of GTP and calcium ions in modulating activity. , 1987, The Journal of biological chemistry.

[158]  L. Fesus,et al.  Lipids associated with tissue transglutaminase. , 1987, Biochimica et biophysica acta.

[159]  S. N. Murthy,et al.  Identification of transglutaminase substrates in inside-out vesicles from human erythrocytes: immunoblotting with anti-dansyl antibody. , 1986, Biochemical and biophysical research communications.

[160]  P. Bungay,et al.  Activation of transglutaminase at calcium levels consistent with a role for this enzyme as a calcium receptor protein , 1985, Bioscience reports.

[161]  K. Lennert,et al.  Alternative myelomonocytic differentiation of HL-60 reflects dual prospective potency of promyelocytes in human. , 1984, Cellular immunology.

[162]  P. Bungay,et al.  The inhibition of glucose-stimulated insulin secretion by primary amines. A role for transglutaminase in the secretory mechanism. , 1984, The Biochemical journal.

[163]  R. Gomis,et al.  Transglutaminase activity in pancreatic islets. , 1983, Biochimica et biophysica acta.

[164]  W. D. de Jong,et al.  beta-Crystallin: endogenous substrate of lens transglutaminase. Characterization of the acyl-donor site in the beta Bp chain. , 1983, European journal of biochemistry.

[165]  L. Fésüs,et al.  Interaction between tissue transglutaminase and phospholipid vesicles , 1983, FEBS letters.

[166]  L. Lorand,et al.  Lens transglutaminase and cataract formation. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[167]  J. Schrode,et al.  Polyamines as physiological substrates for transglutaminases. , 1980, The Journal of biological chemistry.

[168]  P. W. Cole,et al.  Mechanism of action of guinea pig liver transglutaminase. I. Purification and properties of the enzyme: identification of a functional cysteine essential for activity. , 1966, The Journal of biological chemistry.

[169]  S. Oh,et al.  TNF-alpha mediated NF-kappaB activation is constantly extended by transglutaminase 2. , 2011, Frontiers in bioscience.

[170]  S. Sheu,et al.  Crosstalk signaling between mitochondrial Ca2+ and ROS. , 2009, Frontiers in bioscience.

[171]  J. Tucholski,et al.  The Differential Effects of R580A Mutation on Transamidation and GTP Binding Activity of Rat and Human Type 2 Transglutaminase. , 2008, International journal of clinical and experimental medicine.

[172]  Soo-Youl Kim,et al.  Transglutaminase 2 mediates polymer formation of I-kappaBalpha through C-terminal glutamine cluster. , 2006, The Journal of biological chemistry.

[173]  J. V. Van Beeumen,et al.  Cross-linking of ubiquitin, HSP27, parkin, and alpha-synuclein by gamma-glutamyl-epsilon-lysine bonds in Alzheimer's neurofibrillary tangles. , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[174]  G. Johnson,et al.  Immunoblot analysis reveals that isopeptide antibodies do not specifically recognize the epsilon-(gamma-glutamyl)lysine bonds formed by transglutaminase activity. , 2004, Journal of neuroscience methods.

[175]  K. Santacruz,et al.  Citron BA, SantaCruz KS, Davies PJ, Festoff BWIntron-exon swapping of transglutaminase mRNA and neuronal tau aggregation in Alzheimer's disease. J Biol Chem 276:3295-3301 , 2001 .

[176]  Z. Nemes,et al.  N(epsilon)(gamma-glutamyl)lysine in cerebrospinal fluid marks Alzheimer type and vascular dementia. , 2001, Neurobiology of aging.

[177]  J. E. Folk,et al.  Molecular and catalytic properties of transglutaminases. , 1973, Advances in enzymology and related areas of molecular biology.

[178]  D. Clarke,et al.  The incorporation of amines into protein , 1959 .